Maternal Hypertension Disorders and Neonatal Acute Kidney Injury: Results from the AWAKEN Study
- PMID: 35196719
- PMCID: PMC10981551
- DOI: 10.1055/a-1780-2249
Maternal Hypertension Disorders and Neonatal Acute Kidney Injury: Results from the AWAKEN Study
Abstract
Objective: This study aimed to examine the association between maternal hypertension (HTN) exposure and neonatal acute kidney injury (AKI).
Study design: Retrospective cohort study of 2,162 neonates admitted to 24 neonatal intensive care units (NICUs). Neonates were classified into the following exposure groups: any maternal HTN, chronic maternal HTN, preeclampsia/eclampsia, both, or neither. Demographics, clinical characteristics, and AKI status were compared using Chi-square and analysis of variance. General estimating logistic regression was used to estimate adjusted odds ratios and included a stratified analysis for site of delivery.
Result: Neonates exposed to any maternal HTN disorder had a tendency toward less overall and early AKI. When stratified by inborn versus outborn, exposure to both maternal HTN disorders was associated with a significantly reduced odds of early AKI only in the inborn neonates.
Conclusion: Exposure to maternal HTN, especially preeclampsia/eclampsia superimposed on chronic HTN, was associated with less likelihood of early AKI in the inborn group.
Key points: · Maternal HTN is associated with less neonatal AKI.. · Maternal HTN category is variably associated with AKI.. · Inborn status is an important contributor to this association..
Thieme. All rights reserved.
Conflict of interest statement
We provide here an additional list of other author's commitments and funding sources that are not directly related to this study: D.A. is a consultant for Baxter, CHF solutions, Medtronic Bioporto and the AKI Foundation. He receives grant funding for studies not related to this project from Baxter, CHF solutions, Medtronic, and National Institutes of Health (identifier no.: U34 DK117128) J.C. is a coowner of Sindri Technologies, LLC. She receives funding from the National Institute of Health (NIH) National Institutes of Diabetes and Digestive and Kidney Diseases. (NIDDK; identifier numbers: R01DK110622, R01DK111861, and P50DK096373).
Figures
References
-
- Booker WA. Hypertensive disorders of pregnancy. Clin Perinatol 2020;47(04):817–833 - PubMed
-
- Sutton ALM, Harper LM, Tita ATN. Hypertensive disorders in pregnancy. Obstet Gynecol Clin North Am 2018;45(02):333–347 - PubMed
-
- Broekhuijsen K, Ravelli AC, Langenveld J, et al. Maternal and neonatal outcomes of pregnancy in women with chronic hypertension: a retrospective analysis of a national register. Acta Obstet Gynecol Scand 2015;94(12):1337–1345 - PubMed
-
- Lai J, Syngelaki A, Nicolaides KH, von Dadelszen P, Magee LA. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes. Am J Obstet Gynecol 2021;224(05):518.e1–518.e11 - PubMed
-
- Gestational Hypertension and Preeclampsia. Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222. Obstet Gynecol 2020;135(06):e237–e260 - PubMed
Publication types
MeSH terms
Grants and funding
- R01 DK110622/DK/NIDDK NIH HHS/United States
- L40 DK130155/DK/NIDDK NIH HHS/United States
- U34 DK117128/DK/NIDDK NIH HHS/United States
- L30 DK089619/DK/NIDDK NIH HHS/United States
- R01 DK103608/DK/NIDDK NIH HHS/United States
- UL1TR001449/NH/NIH HHS/United States
- R13 DK139766/DK/NIDDK NIH HHS/United States
- UL1 TR001449/TR/NCATS NIH HHS/United States
- K23 DK131289/DK/NIDDK NIH HHS/United States
- R13 DK121513/DK/NIDDK NIH HHS/United States
- R01 DK111861/DK/NIDDK NIH HHS/United States
- UL1 TR001417/TR/NCATS NIH HHS/United States
- P50 DK096373/DK/NIDDK NIH HHS/United States
